Success for New ADHD Patch
There are patches for quitting smoking, and patches for birth control — so why not a patch for ADHD? Early clinical trials suggest that a methylphenidate transdermal system (MTS), or patch, demonstrated statistically significant reductions in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) and was generally well tolerated in patients aged 6 to 12.
